Open Orphan PLC (ORPH) Signs Preferred Partner Agreement November 11, 2019 – Posted in: Open Orphan (ORPH)

Open Orphan, a European-focussed, rare and orphan drug consulting services platform company, is pleased to announce the signing of a preferred partner agreement between Open Orphan and Ipsen Group (“Ipsen”). The agreement selects Venn Life Sciences (“Venn”), which is part of the Open Orphan group, as the preferred partner for Ipsen’s Data Management and Biostatistics. The preferred vendor structure will last for a 3-year period. This partnership has already delivered substantial revenues for the Open Orphan group…